MCT-485 is a low molecular weight synthetic dsRNA with tumor cytolytic properties. The mechanism of action and properties of
MCT-485 are:
There are other agents in development that are directly delivered to tumors with such a two-pronged mechanism of action: oncolytic viruses, plasmids encoding biological response modifiers, or TNF-alpha expressed by various vectors. MCT-485 offers an easy to manufacture, low cost alternative, with a potentially improved therapeutic index.